UNDERSTANDING OUTFLOW TRACT DEFECTS IN DIGEORGE SYNDROME--CHROMOSOME ENGINEERING
了解迪乔治综合征的流出道缺陷——染色体工程
基本信息
- 批准号:6593873
- 负责人:
- 金额:$ 17.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The hemizygous deletion of a chromosomal region of human 22q11 is the
genetic basis for several developmental defects with variable clinical
severity. The clinical presentations may fit the diagnostic criteria for
DiGeorge syndrome (DGS), Velocardiofacial syndrome (VCFS) or be very mild
or complex. Approximately 80% of patients with a 22q11 deletion (de122q11)
presents with a congenital heart defects, mostly of conotruncal origin and
affecting the outflow tract of the heart. Heart defects represent the most
dramatic clinical findings and are responsible for virtually all the early
deaths in these patients. As the 22q11 deletion is one of the most
frequent chromosomal deletions associated with an anomalous phenotype
known in humans, this genetic lesions represents an important cause of
heart defects. Furthermore, we have shown that for certain specific
defects, such as interrupted aortic arch type B, the deletion is found in
50% of the cases, hence representing a major genetic cause for this
anomaly. A 'critical region' the deletion of which is sufficient to
produce the de122q11 phenotype has been delineated. As of today, at least
9 genes have been identified in this 300-400 kb interval. However, it is
still unknown whether or not any of these genes is etiologically important
for the phenotype or whether this is a single or multiple gene defect.
We propose a novel and powerful approach for the modeling of this
important deletion syndrome. We will use chromosome engineering to
generate mouse deletions which simulate the human deletion. Deletions will
be generated using the Cre-loxP strategy in embryonic stem (ES) cells.
Mice carrying the deficiencies will be obtained to test the phenotypic
effects of the deficiencies. Transgenic rescue experiments will be
performed to complement in vivo the deficiencies and identify a genomic
segment sufficient to rescue the phenotype. With these approaches we will
be able to dissect genetically the mechanisms which lead to the
developmental heart defects typical of the de122q11 phenotype.
人类22q11染色体区域的半合子缺失是
几种不同临床发育缺陷的遗传学基础
严肃性。临床表现可能符合以下诊断标准
DiGeorge综合征(DGS)、血管心面综合征(VCFS)或非常轻微
或者很复杂。约80%的患者22q11缺失(De122q11)
表现为先天性心脏缺陷,大多起源于圆锥干和
影响心脏流出道的。心脏缺陷是最常见的
戏剧性的临床表现,并对几乎所有早期
这些患者的死亡人数。因为22q11的缺失是最多的
与异常表型相关的频繁的染色体缺失
在人类中已知,这种遗传损伤是导致
心脏缺陷。此外,我们已经表明,对于某些特定的
缺陷,如B型主动脉弓中断,该缺失见于
50%的病例,因此这是一个主要的遗传原因
异常点。“关键区域”,删除该区域就足以
产生de122q11的表型已经确定。至少到今天为止,
在这个300-400kb的区间内,已鉴定出9个基因。然而,它是
目前还不清楚这些基因中是否有任何在病因学上是重要的
对于表型或这是单基因缺陷还是多基因缺陷。
我们提出了一种新颖而强大的方法来对此进行建模
重要的缺失综合征。我们将使用染色体工程来
生成模拟人工删除的鼠标删除。删除将
在胚胎干细胞(ES)中使用Cre-loxP策略产生。
将获得携带缺陷的小鼠来测试表型
这些缺陷的影响。转基因救援实验将是
以补充体内的缺陷并识别基因组
足以挽救表型的片段。通过这些方法,我们将
能够从基因上剖析导致
典型的de122q11表型的发育性心脏缺陷。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTONIO BALDINI其他文献
ANTONIO BALDINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTONIO BALDINI', 18)}}的其他基金
Defnination of a Genetic Pathway Required for Normal Aortic Arch Development
正常主动脉弓发育所需遗传途径的定义
- 批准号:
6999055 - 财政年份:2004
- 资助金额:
$ 17.52万 - 项目类别:
A GENETIC PATHWAY REQUIRED FOR PHARYNGEAL ARCH DEVELOPME
咽弓发育所需的遗传途径
- 批准号:
6458336 - 财政年份:2002
- 资助金额:
$ 17.52万 - 项目类别:
UNDERSTANDING OUTFLOW TRACT DEFECTS IN DIGEORGE SYNDROME--CHROMOSOME ENGINEERING
了解迪乔治综合征的流出道缺陷——染色体工程
- 批准号:
6594622 - 财政年份:2002
- 资助金额:
$ 17.52万 - 项目类别:
A GENETIC PATHWAY REQUIRED FOR PHARYNGEAL ARCH DEVELOPME
咽弓发育所需的遗传途径
- 批准号:
6622859 - 财政年份:2002
- 资助金额:
$ 17.52万 - 项目类别:
相似海外基金
Development of micropore devise to detect chromosome aberrations
开发检测染色体畸变的微孔装置
- 批准号:
22K19318 - 财政年份:2022
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Induction of chromosome aberrations by Pulse Genome Editing system in mouse intestinal tumor
脉冲基因组编辑系统在小鼠肠道肿瘤中诱导染色体畸变
- 批准号:
19K07701 - 财政年份:2019
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Environmental exposure and chromosome aberrations in birds
鸟类的环境暴露和染色体畸变
- 批准号:
398776-2010 - 财政年份:2010
- 资助金额:
$ 17.52万 - 项目类别:
University Undergraduate Student Research Awards
CLINICAL INVESTIGATION OF THE PATIENT WITH CHROMOSOME ABERRATIONS
染色体畸变患者的临床研究
- 批准号:
7204855 - 财政年份:2005
- 资助金额:
$ 17.52万 - 项目类别:
Development of array based comparative genomic hybridization (CGH) as a diagnostic tool for cryptic chromosome aberrations in congenital disorders
开发基于阵列的比较基因组杂交(CGH)作为先天性疾病中隐性染色体畸变的诊断工具
- 批准号:
17390099 - 财政年份:2005
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical investigation of the patient with chromosome aberrations
染色体畸变患者的临床调查
- 批准号:
7043558 - 财政年份:2004
- 资助金额:
$ 17.52万 - 项目类别:
Induction of DNA damage and its fixation as chromosome aberrations by azo dyes in mouse multiple organs
偶氮染料在小鼠多个器官中诱导 DNA 损伤及其作为染色体畸变的固定
- 批准号:
14560277 - 财政年份:2002
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Changeable aspects of radiation-induced chromosome aberrations during early development of the zygote
受精卵早期发育过程中辐射引起的染色体畸变的变化
- 批准号:
13680615 - 财政年份:2001
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Involvement of telonomic instability in induction of delayed chromosome aberrations by ionizing radiation
端粒组不稳定性参与电离辐射延迟染色体畸变的诱导
- 批准号:
11680552 - 财政年份:1999
- 资助金额:
$ 17.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)